3 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Terminated 3 |
Follow Phosphorus Metabolism Disorders: new trials by email Literature Review of Phosphorus Metabolism Disorders trials Research Report on Phosphorus Metabolism Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Ferric Citrate to Improve Inflammation and Lipid Levels Ferric Citrate - End Stage Renal Disease, Hyperphosphatemia | Phase 4 | Terminated | Winthrop University Hospital | 38 | 2015-07-01 | 2023-04-20 |
| Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol Calcitriol, Paricalcitol - Kidney Failure, Secondary Hyperparathyroidism | Phase 4 | Terminated | Winthrop University Hospital | 16 | 2012-11-01 | 2023-11-07 |
| Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5 Lanthanum carbonate - Kidney Diseases | Phase 4 | Terminated | Shire | 68 | 2007-05-22 | 2021-05-25 |
Hyperphosphatemia (3) · Hypercalcemia (1) · Hyperparathyroidism, Secondary (1) · Kidney Diseases (1) · Kidney Failure, Chronic (1) · Renal Insufficiency (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Male Urogenital Diseases (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Kidney Diseases (2) · Calcium Metabolism Disorders (1) · Chronic Disease (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Hyperparathyroidism (1) · Parathyroid Diseases (1)
Calcitriol (1) · ferric citrate (1) · lanthanum carbonate (1) · paricalcitol (1)
Winthrop University Hospital (2) · Shire (1)
United States (2) · Austria (1) · Belgium (1) · Denmark (1) · Germany (1) · Italy (1) · Netherlands (1)
Candace Grant, MD (1) · Shayan Shirazian, MD (1)